Skip to main content

Breast Cancer Diagnosis by Scintimammography: A Meta-analysis and Review of the Literature

Breast Cancer Research and Treatment volume 80, pages 115–126 (2003)Cite this article

Abstract

Scintimammography is a relatively new, non-invasive diagnostic modality in the evaluation of breast cancer. The purpose of the current study was to review the existing literature on the accuracy of scintimammography in the diagnosis of breast cancer. A search of all articles published between 1st January 1967 and 31st December 1999 was conducted. A total of 64 unique studies were selected. Each scientific paper was reviewed for scientific merit by an epidemiologist, a surgeon and a surgical resident. Assessment of scientific merit was based on a scoring scheme developed for the study. The articles included in this review reported data on a total of 5340 patients assessed for breast cancer with scintimammography. The aggregated summary estimates on these patients were sensitivity: 85.2% and specificity: 86.6%. For patients with a palpable mass the sensitivity and specificity were 87.8 and 87.5%, respectively. For patients without a palpable mass the sensitivity was 66.8% and that for specificity was 86.9%. The results of this review have shown that scintimammography may be used effectively as an adjunct to mammography and physical examination in the diagnosis of breast cancer.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. American Cancer Society: Cancer Facts and Figures 1999. American Cancer Society, Atlanta, GA, 1999

    Google Scholar 

  2. Sondik EJ: Breast cancer trends. Incidence, mortality and survival. Cancer 74: 995-999, 1994

    Google Scholar 

  3. Fever EJ, Wu LM, Boring CC: The lifetime risk of developing breast cancer. JNCL 85: 892-897, 1993

    Google Scholar 

  4. Cox PH, Belfer AJ, Van der Pompe WB: Thallium-201 chloride uptake in tumors, a possible complication in heart scintigraphy. Brit J Radiol 49: 767-768, 1976

    Google Scholar 

  5. Campeau RJ, Kronemer KA, Sutherland CM: Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor. Clin Nucl Med 17: 936-937, 1992

    Google Scholar 

  6. Williams MB, Schnall MD: Future imaging in the diagnosis of breast diseases. Radiology 206: 297-300, 1998

    Google Scholar 

  7. Kopans DB: The positive predictive value of mammography. Am J Roentgenol 158: 521-526, 1992

    Google Scholar 

  8. Pillsbury SG, Haugen JA, Roux S: Reliability of multimodal evaluation of abnormal screening mammogram results. Am J Obstet Gynecol 174: 1683-1687, 1996

    Google Scholar 

  9. Mann BD, Giuliano AE, Bassett LW, Barber MS, Hallauer W, Morton DL: Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg-Chicago 118: 23-24, 1983

    Google Scholar 

  10. Khalkhali I, Mena I, Diggles L: Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 21: 357-362, 1994

    Google Scholar 

  11. Dunwald LK, Hartnett SD, Mankoff DA: Utility and reproducibility of semiquantitative analysis of sestamibi breast images. J Nucl Med Technol 25: 106-109, 1997

    Google Scholar 

  12. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW: Ten-year risk of false positive screening mammograms and clinical breast examinations. NEJM 383: 1089-1096, 1998

    Google Scholar 

  13. Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L: 99mTcantigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases. Anticancer Res 17: 1615-1618, 1997

    Google Scholar 

  14. Nishiyam Y, Yamamoto Y, Kawasaki Y, Satoh K, Takashima H, Ohkawa M, Tanabe M: Accumulation of Tc-99m MIBI in breast lymphomacomparison with Ga-67 citrate. Ann Nucl Med 10: 429-432, 1996

    Google Scholar 

  15. Chandramouly BS, Tiu S, Castronuovo JJ: Uptake of gallium in the breasts. Semin Nucl Med 14: 149-151, 1984

    Google Scholar 

  16. de Jong M, Bernard BF, Breeman WA, Ensing G, Benjamins H, Bakker WH, Visser TJ, Krenning EP: Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines. Eur J Nucl Med 23: 1361-1366, 1996

    Google Scholar 

  17. Hillner BE: Decision analysis: MIBI imaging of nonpalpable breast abnormalities. J Nucl Med 38: 1772-1778, 1997

    Google Scholar 

  18. Akcay MN, Akin Y, Karabag B, Ozcan O, Oren D: Tc-99mtetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI. lin Nucl Med 22: 832-834, 1997

    Google Scholar 

  19. Alonso JC, Soriano A, Zarca MA, Guerra P, Alcazar R, Molino C: Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionucleotides in patients with non-conclusive mammography. Anticancer Res 17: 1661-1665, 1997

    Google Scholar 

  20. Arslan N, Ozturk E, Ilgan S, Urhan M, Karacalioglu O, Pekcan M, Tufan T, Bayhan H: 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Nucl Med Commun 20: 317-325, 1999

    Google Scholar 

  21. Bajc M, Ingvar C, Palmer J: Dynamic indium-111-pentetreotide scintigraphy in breast cancer. J Nucl Med 37: 622-626, 1996

    Google Scholar 

  22. Batista JF, Solano ME, Oliva JP, Rodriguez JL, Gomez J, Stusser RJ, Sanchez E: Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours. Nucl Med Commun 18: 338-340, 1997

    Google Scholar 

  23. Becherer A, Helbich T, Staudenherz A, Jakesz R, Kubista E, Lehner R, Rudas M, Teleky B, Kltter K, Leitha T: The diagnostic value of planar and SPET scintimammography in different age groups. Nucl Med Commun 18: 710-718, 1997

    Google Scholar 

  24. Berghammer P, Obwegeser R, Mullauer-Ertl S, Karanikas G, Wiltschke C, Kubista E, Sinzinger H, Zielinski C: 99m-Tctetrofosmin scintigraphy and breast cancer. Gynecol Oncol 73: 87-90, 1999

    Google Scholar 

  25. Bongers V, Borel Rinkes IHM, Sie-Go DM, Pijnappel R, de Hoog P, van Rijk P: Detection of malignant breast tumours in dense breast tissue: results of 99mTc-tetrofosmin scintimammography related to surgery. Eur J Surg Oncol 25: 152-156, 1999

    Google Scholar 

  26. Burak Z, Argon M, Memis A, Erdem S, Balkan Z, Duman Y, Usten EE, Erhan Y, Ozkilic H: Evaluation of palpable breast masses with 99cTcm-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 15: 604-612, 1994

    Google Scholar 

  27. Buscombe JR, Cwilka JB, Thakrar DS, Parbhoo SP, Hilson AJ: Prone SPET scintimammography. Nucl Med Commun 20: 237-245, 1999

    Google Scholar 

  28. Cancroft E, Goldfarb CR: Breast Scintigraphy as an imaging modality in the diagnosis of breast masses. Semin Nucl Med 11: 289-300, 1981

    Google Scholar 

  29. Carril JM, Gomez-Barquin R, Quirce R, Tabuenca O, Uriarte I, Montero A: Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy. Anticancer Res 17: 1677-1682, 1997

    Google Scholar 

  30. Chen SL, Yin YQ, Chen JX, Sun XG, Xiu Y, Liu WG, Liu M, Zhu WM, Zhang YB: The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard. Anticancer Res 17: 1695-1698, 1997

    Google Scholar 

  31. Chiti A, Agresti R, Maffioli LS, Tomasic G, Savelli G, Crippa F, Pilotti S, Greco M, Bombardieri E: Breast cancer staging using technetium-99m sestamibi and indium-111 pentreotride single photon emission tomography. Eur J Nucl Med 24: 192-196, 1997

    Google Scholar 

  32. Cimitan M, Volpe R, Candiani E, Gusso G, Ruffo R, Borsatti E, Massarut S, Rossi C, Morassut S, Carbone A: The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Eur J Nucl Med 22: 1110-1117, 1995

    Google Scholar 

  33. Clifford EJ, Lugo-Zamudio C: Scintimammography in the diagnosis of breast cancer. Am J Surg 172: 483-486, 1996

    Google Scholar 

  34. Cuschieri A, Hutchinson F, Neill GDS, Wisbey ML, Wood RA, Preece P, Clark J: Scintiscanning of the breast with 99Tcm-diethylene triamine penta-acetic acid-a prospective blind evaluation. Brit J Surg 68: 147-149, 1981

    Google Scholar 

  35. Cutrone JA, Khalkhali I, Yospur LS, Diggles L, Weinberg I, Pong EM, Tolmos J, Vargas MP, Vargas HI: Tc99m sestamibi scintimammography for the evaluation of breast masses in patients with radiographically dense breasts. Breast J 5: 383-388, 1999

    Google Scholar 

  36. Cwikla JB, Buscombe JR, Parbhoo SP, Kelleher SM, Thakrar DS, Hinton J, Crow J, Derry A, Hilson AJ: Use of 99Tcm-MIBI in the assessment of patients with suspected recurrent breast cancer. Nucl Med Commun 19: 649-655, 1998

    Google Scholar 

  37. Danielson R, Bone B, Gad A, Sylvan M, Aspelin P: Sensitivity and specificity of planar scintimammography with 99mTcsestamibi. Acta Radiol 40: 394-399, 1999

    Google Scholar 

  38. De Vincentis G, Scoparino F, Pani R, Pelligrini R, Soluri A, Ierardi M, Ballesio L, Weinberg IN, Pergola A: 99mTcMIBI scintimammography with a high resolution single tube gamma camera. Anticancer Res 17: 1627-1630, 1997

    Google Scholar 

  39. den Outer AJ, Pauwels AKJ, Zwaveling A, Puylaert JB, Hermans J, De Lange EE: Breast scintigraphy with 99mTcdiethylene triamene penta-acetic acid for the detection of malignant disease. Brit J Surg 73: 613-614, 1986

    Google Scholar 

  40. De Vincentis G, Gianni W, Pani R, Cacciafesta M, Pellegrini R, Soluri A, Troisi G, Marigliano V, Scoparino F: Role of 99mTc-sestamibi scintimammography by SPEMcamera in the management of breast cancer in the elderly. Breast Cancer Res Tr 48: 159-163, 1998

    Google Scholar 

  41. Fenlon HM, Phelan N, Tierney S, Gorey T, Ennis JT: Tc-99m tetrofosmin scintigraphy as an adjunct to plain film mammography in palpable breast lesions. Clin Radiol 53: 17-24, 1998

    Google Scholar 

  42. Flanagan DA, Gladding SB, Lovell FR: Can scintimammography reduce "unneccessary": biopsies? Am Surgeon 64: 670-673, 1998

    Google Scholar 

  43. Helbich TH, Becherer A, Trattnig S, Leitha T, Kelkar P, Seifert M, Gnant M, Staudehherz A, Rudas M, Wolf G, Mostbeck GH: Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology 202: 421-429, 1997

    Google Scholar 

  44. Howarth D, Sillar R, Lan L, Clark D, Miles T: Scintimammography: an adjunct test for the detection of breast cancer. MJA 170: 588-591, 1999

    Google Scholar 

  45. Kao CH, Wang SJ, Liu TJ: The use of technetium-99mmethoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432-436, 1994

    Google Scholar 

  46. Khalkhali I, Cutrone JA, Diggles E, Klein SR: Scintimammography with Tc-99m sestamibi. Acta Med Aust 24: 46-49, 1997

    Google Scholar 

  47. Khayat G, Achram M, Rizk G: The role of breast scintigraphy in detecting breast masses. Brit J Radiol 58: 721-724, 1985

    Google Scholar 

  48. Lam WWM, Yang WT, Chan YL, Stewart IE, King W, Metreweli C: Role of MIBI breast scintigraphy in evaluation of palpable breast lesions. Brit J Radiol 69: 1152-1158, 1996

    Google Scholar 

  49. Lee VW, Sax EJ, McAneny DB, Pollack S, Blanchard RA, Beazley RM, Kavanah MT, Ward RJ: A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 34: 2095-2100, 1993

    Google Scholar 

  50. Lee JK, Kao CH, Sun SS: Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses. Oncol Rep 6: 659-663, 1999

    Google Scholar 

  51. Lind P, Umschaden W, Forsthuber E, Oman J, Kerschbaumer K, Gallowitsch HJ, Mikosch P, Kresnik E, Molnar M, Gomez I: Scintimammography using Tc-99m tetrofosmin. Acta Med Aust 24: 50-54, 1997

    Google Scholar 

  52. Maffioli L, Agresti R, Chiti A, Crippa F, Gasparini M, Greco M, Bombardieri E: Prone scintimammography in patients with non-palpable breast lesions. Anticancer Res 16: 1269-1274, 1996

    Google Scholar 

  53. Mangkharak J, Patanachak C, Podhisuwan K, Pleehachinda R: The evaluation of combined scintimammography and tumor markers in breast cancer patients. Anticancer Res 17: 1611-1614, 1997

    Google Scholar 

  54. Mangkharak J: Scintimammography (SMM) in breast cancer patients. J Med Assoc Thai 82: 242-249, 1999

    Google Scholar 

  55. Mansi L, Rambaldi PF, Procaccini E, Gregorio FD, Laprovitera A, Pecori B, Vecchio WD: Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 23: 932-939, 1996

    Google Scholar 

  56. Markopoulos C, Sampalis F, Zerva C, Kiriaki D, Kitsou E, Alevizou-Terzaki V, Gogas J. 99mTc tetrofosmin imaging in breast cancer. Eur J Gynaecol Oncol 19: 163-166, 1998

    Google Scholar 

  57. Maublant J, de Latour M, Mestas D, Clemenson A, Charrier S, Feillel V, Le Bouedec G, Kaufmann P, Dauplat J, Veyre A: Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 37: 922-925, 1996

    Google Scholar 

  58. Maurer AH, Caroline DF, Jadali FJ, Manzone TA, Maier WP, Au FC, Schnall SF: Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy. J Nucl Med 36: 1696-1700, 1995

    Google Scholar 

  59. McQuarrie SA, MacLean GD, Boniface GR, Goldberg K, McEwan AJB: Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II study. Eur J Nucl Med 24: 381-389, 1997

    Google Scholar 

  60. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E: Technetium-99m-MIBI scintimammography in palpable and non-palpable breast lesions. J Nucl Med 39: 86-91, 1998

    Google Scholar 

  61. Melloul M, Paz A, Ohana G, Laver O, Michalevich D, Koren R, Woloch Y, Gal R: Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med 40: 376-380, 1999

    Google Scholar 

  62. Mondal A, Sharma R, Chakravarty KL, Mishra P, Sahay K, Bhatnagar A, Gupta A, Sawroop K: Delayed Tc-99m citrate scintigraphy in the evaluation of palpable breast masses. Clin Nucl Med 24: 309-313, 1999

    Google Scholar 

  63. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC, Vilcoq J: Primary breast cancer imaging with technitium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 23: 980-986, 1996

    Google Scholar 

  64. Palmedo H, Schomburg A, Grunwald F, Mallmann P, Krebs D, Biersack HJ: Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 37: 626-630, 1996

    Google Scholar 

  65. Palmedo H, Biersack HJ, Lastoria S, Maublant J, Prats E, Stegner HE, Bourgeois P, Hustinx R, Hilson AJ, Bischof-Delaloye A: Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 25: 375-385, 1998

    Google Scholar 

  66. Pauwels EKJ, Den Outer AJ, Hermans J, Obermann WR, Zwaveling A: Scintigraphy of the female breast with Tc-99m-DTPA: a prospective blind evaluation. Am J Physiol Imaging 1: 91-95, 1986

    Google Scholar 

  67. Piccolo S, Lastoria S, Muto P, Bazzicalupo L, Bartiromo A, Salvatore M: Scintimammography with 99mTc-MDP in the detection of primary breast cancer. Q J NuclMed 41: 225-230, 1997

    Google Scholar 

  68. Prats E, Aisa F, Abos DM, Villavieja L, Garcia-Lopez F, Asenjo MJ, Razola P, Banzo J: Mammography and 99mTc-MIBI scintimammography in suspected breast cancer. J Nucl Med 40: 296-301, 1999

    Google Scholar 

  69. Rebello AC, Torres-Avisbal M, Espinosa JE, Diaz C, Vallejo JA, Pacheco C, Pera C, Mateo A: Evaluation of palpable breast masses with 201Tl scintigraphy. Brit J Radiol 68: 1052-1057, 1995

    Google Scholar 

  70. Schillaci O, Scoparino F, Danieli R, Tavolaro R, Picardi V, Cannas P, Colella AC: 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement. Nucl Med Commun 18: 839-845, 1997

    Google Scholar 

  71. Scoparino F, Schillaci O, Ussof W, Nordling K, Capoferro R, De Vincentis G, Danieli R, Ierardi M, Picardi V, Tavolaro R, Colella AC: A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. Anticancer Res 17: 1631-1634, 1997

    Google Scholar 

  72. Sehweil AM, McKillop JH, Milroy R, Sayed MA, Ziada G, Banham SW, Davidson KG, Ragib A, Omar YT, Abdel-Dayem HM: 201Tl scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun 11: 263-269, 1990

    Google Scholar 

  73. Sillar R, Howarth D, Clark D: The initial Australian experience of technetium-99m sestamibi scintimammography: a complementary test in the management of breast cancer. Aust NZ J Surg 67: 433-437, 1997

    Google Scholar 

  74. Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C: Evaluation of mammographic lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Zbl Gynakol 119: 6-11, 1997

    Google Scholar 

  75. Taillefer R, Robidoux A, Lampert R, Turpin S, Laperriere J: Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36: 1758-1765, 1995

    Google Scholar 

  76. Tiling R, Khalkhali I, Sommer H, Linke R, Moser R, Willemsen F, Pfluger T, Tatsch K, Hahn K: Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography. Nucl Med Commun 19: 55-62, 1998

    Google Scholar 

  77. Tolmos J, Cutrone JA, Wang B, Vargas HI, Stuntz M, Mishkin FS, Diggles LE, Venegas RJ, Klein SR, Khalkhali I: Scintimammography analysis of nonpalpable breast lesions previously identified by conventional mammography. J Natl Cancer I 90: 846-849, 1998

    Google Scholar 

  78. Uriarte I, Carril JM, Quirce R, Gutierrez-Mendiguchia C, Blanco I, Banzo I, Vega A, Hernandez A: Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions. Eur J Nucl Med 25: 491-496, 1998

    Google Scholar 

  79. Villanueva-Meyer J, Leonard MH, Briscoe E, Cesani F, Ali SA, Rhoden S, Hove M, Cowan D: Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 37: 926-930, 1996

    Google Scholar 

  80. Waxman AD, Ramanna L, Memsic LD, Foster CE, Silberman AW, Gleischman SH, Brenner RJ, Brachman MB, Kuhar CJ, Yadegar J: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 34: 18-23, 1993

    Google Scholar 

  81. Yuen-Green M, Wasnich R, Caindec-Ranchez S, Davis J: New method for breast cancer detection using Tc-99m sestamibi scintimammography. Hawaii Med J 55: 26-28, 1996

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Surgery, Montreal General Hospital, McGill University Health Center, Que., Canada

    Moishe Liberman, David S. Mulder & John S. Sampalis

  2. Department of Clinical Epidemiology, Montreal General Hospital, McGill University Health Center, Que., Canada

    Moishe Liberman & John S. Sampalis

  3. Department of Surgery, Hôpital Sacre Coeur, Université de Montreal, Montreal, Que., Canada

    Fotini Sampalis & John S. Sampalis

Authors
  1. Moishe Liberman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fotini Sampalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David S. Mulder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John S. Sampalis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Liberman, M., Sampalis, F., Mulder, D.S. et al. Breast Cancer Diagnosis by Scintimammography: A Meta-analysis and Review of the Literature. Breast Cancer Res Treat 80, 115–126 (2003). https://doi.org/10.1023/A:1024417331304

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024417331304

  • breast cancer
  • diagnosis
  • mammogram
  • meta-analysis
  • scintimammography
  • screening